Mobile EHR provider drchrono has announced an integration partnership with Inferscience, a provider of point-of-care Clinical Decision Support and HCC Risk Adjustment technologies
Infera, is now available to drchrono’s growing network of more than 100,000 medical professionals who can now more efficiently standardize evidence-based care delivery and more effectively risk adjust their patient populations.
“Inferscience delivers a valuable service for care providers,” said Sunil Nihalani, CEO and Founder, Inferscience in a statement. “Providers and patients will greatly benefit from our partnership with drchrono. Our goal is to improve quality and patient outcomes by providing users of drchrono with timely, patient-specific actionable recommendations at the point of care. Our solution not only improves the patient-doctor experience; it truly improves clinical care. Now, with the capability to more effectively risk assess and adjust patient populations we are also improving practice revenues. We are extremely excited to add drchrono to our expanding partnership program.”
